Skip to main content

Advertisement

Log in

Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care

  • IM - ORIGINAL
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic disease with unknown etiology and poor prognosis. Little is known about the epidemiology of this disease; most of the studies are limited by small and restricted cohort studies. We aim to investigate the epidemiology of IPF in the Italian primary care setting using the Health Search Database (HSD) between January 2002 and June 2017. In an attempt to define cases of IPF we adopted iterative combinations of International Classification of Diseases Ninth Revision (ICD-9-CM) and other clinical investigations according to three different operational Algorithms. Incidence and prevalence rate, according to the three Algorithms defining IPF, were calculated and the association with candidate determinants [sex, age, gastro-esophageal reflux (GERD) and smoking status] was evaluated. We identified 1,104,307 eligible patients. The prevalence rate of IPF varies between 2.6 to 24.3 per 100.000 person-year, using algorithm 1 and from 0.8 to 7 using algorithm 3. The incidence rate of IPF varies between 1.25 and 3.77 per 100.000 person-years, using algorithm 1 and from 0.10 to 1.61 using algorithm 3. The mean adjusted incidence rate ratio of IPF, using algorithm 1, is 2.33 (95% CI 2.11–2.57) per 100.000 person-years. Over the study years, the trend of prevalence was statistically significantly increasing while the incidence rate started to increase in the last 3 years. The analyses on candidate determinants showed that patients aged 61 years or older, those suffering from GERD, and former smokers were statistically significantly at greater risk of incurring IPF. To our knowledge, this is one of the first European IPF epidemiological studies conducted in primary care. The increase of the incidence rates is likely due to a growing awareness for IPF among General Practitioners, while the increase of prevalence rates may be due to an increase of survival, a result of recent advances in the diagnosis, management and therapies for the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Raghu G, Collard HR, Egan JJ et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183(6):788–824

    Article  Google Scholar 

  2. Caminati A, Harari S (2010) IPF: new insight in diagnosis and prognosis. Respir Med 104(Suppl 1):S2–10

    Article  Google Scholar 

  3. Luppi F, Cerri S, Taddei S, Ferrara G, Cottin V et al (2015) Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review. Intern Emerg Med 10(4):401–411

    Article  Google Scholar 

  4. Fernández Pérez ER, Daniels CE, Schroeder DR et al (2010) Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis a population-based study. Chest 137(1):129–137

    Article  Google Scholar 

  5. Barbagli E, Di Masi M, Perruzza M et al (2009) The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis. Intern Emerg Med 4(6):535–537

    Article  Google Scholar 

  6. Ryu JH, Moua T, Daniels CE et al (2014) Idiopathic pulmonary fibrosis: evolving concepts. Mayo Clin Proc 89(8):1130–1142

    Article  Google Scholar 

  7. Wolters PJ, Collard HR, Jones KD (2014) Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol 9:157–179

    Article  CAS  Google Scholar 

  8. Conti S, Harari S, Caminati A et al (2018) The association between air pollution and the incidence of idiopathic pulmonary fibrosis in Northern Italy. Eur Respir J 51(1)

  9. Johannson KA, Strâmbu I, Ravaglia C et al (2017) Antiacid therapy in idiopathic pulmonary fibrosis: more questions that answers. Lancet Respir Med 5(7):591–598

    Article  Google Scholar 

  10. Dipaola F, Galli A, Selmi C, Furlan R (2015) Efficacy of medical therapy in a case of idiopathic pulmonary fibrosis due to gastroesophageal reflux disease. Intern Emerg Med 10(4):401–411

    Article  Google Scholar 

  11. Armanios MY, Chen JJ-L, Cogan JD et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007;356:1317–1326.

  12. Liu T, Ullenbruch M, Choi YY et al (2013) Telomerase and telomere length in pulmonary fibrosis. Am J Respir Cell Mol 49(2):260–268

    Article  CAS  Google Scholar 

  13. Lederer D, Martinez FJ (2018) Idiopathic pulmonary fibrosis. N Engl J Med 378(19):1811–1823

    Article  CAS  Google Scholar 

  14. Coultas DB, Zumwalt RE, Black WC et al (1994) The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 150(4):967–972

    Article  CAS  Google Scholar 

  15. Raghu G, Jardin MR, Myers J et al (2018) Diagnosis of idiopathic pulmonary fibrosis an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 198(5):e44–e68

    Article  Google Scholar 

  16. Hutchinson J, Fogarty A, Hubbard R, McKeever T (2015) Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J 46(3):795–806

    Article  Google Scholar 

  17. Caminati A, Madotto F, Cesana G, Conti S, Harari S (2015) Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation. Eur Respir Rev 24:436–444

    Article  Google Scholar 

  18. Gribbin J, Hubbard R, Le Jeune I, Smith CJ, West J, Tata LJ (2006) Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 61:980–985

    Article  CAS  Google Scholar 

  19. Navaratnam V, Fleming KM, West J et al (2011) The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax 66:462–467

    Article  CAS  Google Scholar 

  20. Strongman H, Kausar I, Maher TM (2018) Incidence, prevalence, and survival of patients with idiopathic pulmonary fibrosis in the UK. Adv Ther 35:724–736

    Article  Google Scholar 

  21. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G (2006) Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174(7):810–816

    Article  Google Scholar 

  22. Hopkins RV, Burke N, Fell C, Dion G, Kolb M (2016) Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada. Eur Respir J 48:187–19520

    Article  Google Scholar 

  23. Ntsuizaka M, Chiba H, Kuronuma K et al (2014) Epidemiologic survey of japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med 190:773–779

    Article  Google Scholar 

  24. Harari S, Madotto F, Caminati A, Conti S, Cesana G (2016) Epidemiology of idiopathic pulmonary fibrosis in northern Italy. PLoS ONE 11(2):e0147072

    Article  Google Scholar 

  25. Breslow NE (1996) Statistics in epidemiology: the case-control study. J Am Stat Assoc 91(433):14–28

    Article  CAS  Google Scholar 

  26. Cricelli C, Mazzaglia G, Samani F et al (2003) Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med 25(3):254–257

    Article  Google Scholar 

  27. Guglielmi V, Bellia A, Bianchini E, et al. Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care. Endocrine. 2017:1–8.

  28. Filippi A, Vanuzzo D, Bignamini AA, Mizzaglia C, Cricelli C, Catapano AL (2005) The database of Italian general practitioners allows a reliable determination of the prevalence of myocardial infarction. Ital Heart J 6(4):311–314

    PubMed  Google Scholar 

  29. Nurmi H, Selander T, Purokivi M, Kaarteenaho R (2017) Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis. Respir Res 18(1):160

    Article  Google Scholar 

  30. Lee JS, Collard HR, Raghu G et al (2010) Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med 123:304–311

    Article  Google Scholar 

  31. Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D (2012) Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev 21:355–361

    Article  Google Scholar 

  32. Kaunisto J, Salomaa ER, Hodgson U et al (2013) Idiopathic pulmonary fibrosis—a systematic review on methodology for the collection of epidemiological data. BMC Pulm Med 13:53

    Article  Google Scholar 

  33. Raghu G, Chen SY, Yeh WS et al (2014) Idiopathic pulmonary fibrosis in US medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–2011. Lancet Respir Med 2(7):566–572

    Article  Google Scholar 

  34. Ferrara G, Arnheim-Dahlstrom L, Bartley K et al (2019) Epidemiology of pulmonary fibrosis: a cohort study using healthcare data in Sweden. Pulm Ther. https://doi.org/10.1007/s41030-019-0087-9

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alice Biffi.

Ethics declarations

Conflict of interest

Sergio Harari has relationship with drug company Roche, Actelion and Boehringer Ingelheim. In addition to being investigator in trials involving these companies, relationships include lectures and membership of scientific advisory boards and grant for research. Michele Davì is a medical manager, unit Rare Diseases, at Roche S.p.A. Alessandra Ghirardini is a medical unit head, unit Rare Diseases, at Roche S.p.A. Valeria Lovato is a country study manager at Roche S.p.A. Francesco Lapi and Cricelli Claudio has received research grants from Roche for research activities. Alice Biffi and Antonella Caminati have no conflict of interest.

Statement of human and animal rights

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harari, S., Davì, M., Biffi, A. et al. Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care. Intern Emerg Med 15, 437–445 (2020). https://doi.org/10.1007/s11739-019-02195-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-019-02195-0

Keywords

Navigation